| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Ispinesib |
伊斯平斯 |
336113-53-2 |
詳細(xì)
|
| 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE, 7-METHYL-2-(4-MORPHOLINYL)-9-[1-(PHENYLAMINO)ETHYL]- |
|
663619-89-4 |
詳細(xì)
|
| AT9283 |
|
896466-04-9 |
詳細(xì)
|
| BMS-754807 |
|
1001350-96-4 |
詳細(xì)
|
| IPA-3 |
|
42521-82-4 |
詳細(xì)
|
| LJH685 |
2,6-二氟-4-[4-[4-(4-甲基-1-哌嗪基)苯基]-3-吡啶基]苯酚 |
1627710-50-2 |
詳細(xì)
|
| Lys05 |
|
1391426-24-6 |
詳細(xì)
|
| T0901317 |
N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羥基-1-(三氟甲基)乙基]苯基]苯磺酰胺 |
293754-55-9 |
詳細(xì)
|
| IMD-0354 |
N-[3,5-雙(三氟甲基)苯基]-5-氯-2-羥基苯甲酰胺 |
978-62-1 |
詳細(xì)
|
| SU 6656 |
|
330161-87-0 |
詳細(xì)
|
| K02288 |
|
1431985-92-0 |
詳細(xì)
|
| SF1670(PTENinhibitor) |
|
345630-40-2 |
詳細(xì)
|
| Cl-amidine TFA |
|
1043444-18-3 |
詳細(xì)
|
| CCT245737 |
|
1489389-18-5 |
詳細(xì)
|
| LF3 |
|
664969-54-4 |
詳細(xì)
|
| Apigenin |
芹菜素 |
520-36-5 |
詳細(xì)
|
| CM-272 |
化合物CM-272 |
1846570-31-7 |
詳細(xì)
|
| TTNPB |
|
71441-28-6 |
詳細(xì)
|
| Benzenesulfonyl fluoride, 4-(2-aminoethyl)-, hydrochloride (1:1) |
4-(2-氨乙基)苯磺酰氟鹽酸鹽 |
30827-99-7 |
詳細(xì)
|
| eflornithine ,eflornithine hydrochloride hydrate |
依氟鳥氨酸鹽酸鹽一水合物 |
96020-91-6 |
詳細(xì)
|
| OSU-03012 (AR-12) |
2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺 |
742112-33-0 |
詳細(xì)
|
| 4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione |
4-芐基-2-(萘-1-基)-[1,2,4]噻二唑烷-3,5-二酮 |
865854-05-3 |
詳細(xì)
|
| Afuresertib |
|
1047644-62-1 |
詳細(xì)
|
| STF 083010 |
|
307543-71-1 |
詳細(xì)
|
| IM-12 |
|
1129669-05-1 |
詳細(xì)
|
| Mivebresib |
米維布塞 |
1445993-26-9 |
詳細(xì)
|
| MI-503 |
|
1857417-13-0 |
詳細(xì)
|
| Asciminib |
|
1492952-76-7 |
詳細(xì)
|
| Mavacamten |
瑪伐凱泰 |
1642288-47-8 |
詳細(xì)
|
| LXH254,LXH-254 |
|
1800398-38-2 |
詳細(xì)
|
| BMS-1166 |
|
1818314-88-3 |
詳細(xì)
|
| 6-((4-Chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-2-ol |
|
2289690-31-7 |
詳細(xì)
|
| Lonafarnib |
洛那法尼 |
193275-84-2 |
詳細(xì)
|
| Marimastat |
馬立馬司他 |
154039-60-8 |
詳細(xì)
|
| Elesclomol |
伊利司莫 |
488832-69-5 |
詳細(xì)
|
| STAT5-IN-1 |
|
285986-31-4 |
詳細(xì)
|
| Pracinostat (SB939) |
(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羥基丙烯酰胺 |
929016-96-6 |
詳細(xì)
|
| SRT 2104 |
?，斘髁?/td>
| 1093403-33-8 |
詳細(xì)
|
| Vorapaxar |
沃拉帕沙 |
618385-01-6 |
詳細(xì)
|
| AZ20 |
|
1233339-22-4 |
詳細(xì)
|
| 2-D08 |
化合物2-D08 |
144707-18-6 |
詳細(xì)
|
| Pifithrin-μ |
Pifithrin-渭 |
64984-31-2 |
詳細(xì)
|
| GW6471 |
|
880635-03-0 |
詳細(xì)
|
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]環(huán)己烷羧酸 |
936890-98-1 |
詳細(xì)
|
| Zelavespib (PU-H71) |
6-氨基-8-[(6-碘-1,3-苯并二茂-5-基)硫基]-N-異丙基-9H-嘌呤-9-丙胺 |
873436-91-0 |
詳細(xì)
|
| TLR2-IN-C29 |
|
363600-92-4 |
詳細(xì)
|
| SR-18292 |
|
2095432-55-4 |
詳細(xì)
|
| C178 |
N-(二苯并[B,D]呋喃-3-基)-5-硝基呋喃-2-甲酰胺 |
329198-87-0 |
詳細(xì)
|
| SR-717 |
|
2375421-09-1 |
詳細(xì)
|
| Nelfinavir Mesylate |
甲磺酸奈非那韋 |
159989-65-8 |
詳細(xì)
|
| 2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoicacid |
2-環(huán)戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 |
890842-28-1 |
詳細(xì)
|
| AUZ 454 |
|
853299-07-7 |
詳細(xì)
|
| FPS-ZM1 |
|
945714-67-0 |
詳細(xì)
|
| SGC-CBP30 |
|
1613695-14-9 |
詳細(xì)
|
| AZD5582 |
|
1258392-53-8 |
詳細(xì)
|
| WZB-117 |
|
1223397-11-2 |
詳細(xì)
|
| E6446 dihydrochloride |
|
1345675-25-3 |
詳細(xì)
|
| GSK2982772 |
|
1622848-92-3 |
詳細(xì)
|
| 4-(5,6-Dimethoxybenzo[b]thiophen-2-yl)-4-oxobutanoic acid |
|
129425-81-6 |
詳細(xì)
|
| CI-994 |
4-乙酰氨基-N-(2'-氨基苯基)-苯甲酰胺 |
112522-64-2 |
詳細(xì)
|
| Silibinin |
水飛薊賓 |
22888-70-6 |
詳細(xì)
|
| IBMX |
3-異丁基-1-甲基黃嘌呤 |
28822-58-4 |
詳細(xì)
|
| GSK2656157 |
|
1337532-29-2 |
詳細(xì)
|
| Dubermatinib |
|
1341200-45-0 |
詳細(xì)
|
| Unesbulin |
|
1610964-64-1 |
詳細(xì)
|
| Pitavastatin Calcium |
匹伐他汀鈣 |
147526-32-7 |
詳細(xì)
|
| Lonidamine |
氯尼達(dá)明 |
50264-69-2 |
詳細(xì)
|
| 9-[(2-Hydroxyethoxy)Methyl]Guanine |
阿昔洛韋 |
59277-89-3 |
詳細(xì)
|
| Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)- |
硝唑尼特 |
55981-09-4 |
詳細(xì)
|
| PHA-665752 |
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氫-2-氧代-3H-吲哚-3-亞基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷 |
477575-56-7 |
詳細(xì)
|
| FR 180204 |
|
865362-74-9 |
詳細(xì)
|
| ML 141 |
|
71203-35-5 |
詳細(xì)
|
| 3',4',5,7-Tetrahydroxyflavone |
木犀草素 |
491-70-3 |
詳細(xì)
|
| A-1210477 |
無中文名稱 |
1668553-26-1 |
詳細(xì)
|
| Cholesterol |
膽固醇 |
57-88-5 |
詳細(xì)
|
| Monensin sodium salt |
莫能菌素鈉鹽 |
22373-78-0 |
詳細(xì)
|
| SIRTINOL |
2-[[(2-羥基-1-萘基)亞甲基]氨基]-N-(1-苯基乙基)苯甲酰胺 |
410536-97-9 |
詳細(xì)
|
| Nirogacestat |
|
1290543-63-3 |
詳細(xì)
|
| Imaradenant (AZD4635) |
|
1321514-06-0 |
詳細(xì)
|
| 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt(1:1), (2S,5R,6R)- |
氨芐西林鈉 |
69-52-3 |
詳細(xì)
|
| Omeprazole |
奧美拉唑 |
73590-58-6 |
詳細(xì)
|
| PNU-74654 |
|
113906-27-7 |
詳細(xì)
|
| N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-Morpholin-4-yl-propyl)-pyriMidine-2,4-diaMine |
|
1380432-32-5 |
詳細(xì)
|
| TMP-269 |
|
1314890-29-3 |
詳細(xì)
|
| PHA-767491 HCl |
1,5,6,7-四氫-2-(4-吡啶基)-4H-吡咯并[3,2-C]吡啶-4-酮鹽酸鹽 |
942425-68-5 |
詳細(xì)
|
| 4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4E)- |
霉酚酸 |
24280-93-1 |
詳細(xì)
|
| GDC-0575 |
(R)-N-(4-(3-氨基哌啶-1-基)-5-溴-1H-吡咯并[2,3-B]吡啶-3-基)環(huán)丙烷甲酰胺 |
1196541-47-5 |
詳細(xì)
|
| KYA1797K |
|
1956356-56-1 |
詳細(xì)
|
| Autophinib |
|
1644443-47-9 |
詳細(xì)
|
| EX229 |
|
1219739-36-2 |
詳細(xì)
|
| Geldanamycin |
格爾德霉素 |
30562-34-6 |
詳細(xì)
|
| TED-347 |
化合物TED-347 |
2378626-29-8 |
詳細(xì)
|
| ZM 447439 |
|
331771-20-1 |
詳細(xì)
|
| PJ34 hydrochloride |
|
344458-15-7 |
詳細(xì)
|
| Ruboxistaurin hydrochloride |
魯伯斯塔鹽酸鹽 |
169939-93-9 |
詳細(xì)
|
| Bafetinib |
巴氟替尼 |
859212-16-1 |
詳細(xì)
|
| Carbonic Anhydrase IX/XII Inhibitor II(U-104) |
|
178606-66-1 |
詳細(xì)
|
| 3-(3-Aminopropoxy)-N-(2-((3-((4-chloro-2-hydroxyphenyl)carbamoyl)naphthalen-2-yl)oxy)ethyl)-2-naphthamide hydrochloride |
|
1433286-70-4 |
詳細(xì)
|
| 4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol |
|
2289691-01-4 |
詳細(xì)
|
| 5'-D(ATGAAAATCAGGGTTAGG)-3', SODIUM SALT |
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 |
1047953-91-2 |
詳細(xì)
|